Market Overview:
The global selected reaction monitoring (SRM) market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for personalized medicine, rising prevalence of cancer and other diseases, and technological advancements in SRM platforms. The human discovery assay segment is expected to account for the largest share of the global SRM market in 2018. This segment is also projected to grow at the highest CAGR during the forecast period. The human cancer MRM assay segment is expected to grow at a high rate owing to increasing demand for targeted therapies and personalized medicines for cancer patients.
Product Definition:
The definition of Selected Reaction Monitoring is a technique used in mass spectrometry that allows for the detection and quantitation of specific molecules within a sample. The importance of Selected Reaction Monitoring is that it can be used to detect and quantify specific molecules within a sample, which can provide information about the composition and structure of the molecule.
Human Discovery Assay:
Human discovery assay is a new term in the life science industry. It is used to define a research method for testing the drug efficacy of unknown substances or compounds that are found in humans, and it's also known as human pharmacokinetics. The purpose of these assays is to discover new drugs with greater efficiency than conventional ones by screening large numbers of compounds at once.
Human Cancer MRM Assay:
Human cancer MRM assay is used for the detection of mutations in oncogenes. This assay has wide applications in clinical diagnosis and drug development due to its high sensitivity and specificity. The Human Cancer MRM assay helps detect over 600 new gene mutations for each tumor sample tested which makes it a powerful tool in early diagnosis of cancer, thus boosting demand among healthcare professionals towards its usage as well as amongst patients for testing routine blood samples for detecting various types of cancers.
Application Insights:
The market is segmented into hospitals, research institutes, and diagnostic centers. The hospitals segment dominated the overall market in terms of revenue share in 2017. This can be attributed to a large number of tests that are available only at hospital laboratories and the presence of a large patient base with cancer or cardiac diseases for which these tests were developed.
The research institutes segment is expected to grow at a lucrative rate over the forecast period owing to increasing government funding for cancer research coupled with an increase in R&D activities pertaining to MRM assays across various pharmaceutical companies. Increasing R&D investments by pharmaceutical companies have resulted in development of advanced human discovery assay that can detect even minute quantities of drugs within seconds instead of hours as was previously required, thereby driving growth across this region over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biotechnology and pharmaceutical companies, which are engaged in drug discovery and development processes. Moreover, these players are focusing on the launch of novel drugs for treatment of various diseases, thereby driving regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence of cancer and other infectious diseases coupled with growing healthcare expenditure by governments across countries such as China & India & Japan & South Korea among others). Furthermore, rising awareness about early diagnosis is anticipated to fuel regional demand during the forecast period.
Growth Factors:
- Increasing demand for food safety and quality control
- Growing popularity of proteomics and metabolomics research
- Advances in technology that improve the accuracy and speed of mass spectrometry
- Rising number of clinical trials that use SRM to measure biomarkers
- Growing demand for personalized medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Selected Reaction Monitoring Market Research Report
By Type
Human Discovery Assay, Human Cancer MRM Assay, Custom MRM Assays, Human Cardiovascular MRM Assay
By Application
Hospitals, Research Institutes, Diagnostic Centers
By Companies
MRM Proteomics, Sigma-Aldrich, Thermo Fisher Scientific, Alphalyse, Proteomics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Selected Reaction Monitoring Market Report Segments:
The global Selected Reaction Monitoring market is segmented on the basis of:
Types
Human Discovery Assay, Human Cancer MRM Assay, Custom MRM Assays, Human Cardiovascular MRM Assay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research Institutes, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MRM Proteomics
- Sigma-Aldrich
- Thermo Fisher Scientific
- Alphalyse
- Proteomics
Highlights of The Selected Reaction Monitoring Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Discovery Assay
- Human Cancer MRM Assay
- Custom MRM Assays
- Human Cardiovascular MRM Assay
- By Application:
- Hospitals
- Research Institutes
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Selected Reaction Monitoring Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Selected Reaction Monitoring (SRM) is a technique used in chemical and biochemical engineering to monitor the progress of a reaction. SRM involves measuring the concentrations of reactants, products, and byproducts over time. This information can be used to determine whether or not the reaction is proceeding according to plan, and if not, what needs to be done to correct it.
Some of the key players operating in the selected reaction monitoring market are MRM Proteomics, Sigma-Aldrich, Thermo Fisher Scientific, Alphalyse, Proteomics.
The selected reaction monitoring market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Selected Reaction Monitoring Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Selected Reaction Monitoring Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Selected Reaction Monitoring Market - Supply Chain
4.5. Global Selected Reaction Monitoring Market Forecast
4.5.1. Selected Reaction Monitoring Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Selected Reaction Monitoring Market Size (000 Units) and Y-o-Y Growth
4.5.3. Selected Reaction Monitoring Market Absolute $ Opportunity
5. Global Selected Reaction Monitoring Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Selected Reaction Monitoring Market Size and Volume Forecast by Type
5.3.1. Human Discovery Assay
5.3.2. Human Cancer MRM Assay
5.3.3. Custom MRM Assays
5.3.4. Human Cardiovascular MRM Assay
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Selected Reaction Monitoring Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Selected Reaction Monitoring Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Research Institutes
6.3.3. Diagnostic Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Selected Reaction Monitoring Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Selected Reaction Monitoring Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Selected Reaction Monitoring Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Selected Reaction Monitoring Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Selected Reaction Monitoring Demand Share Forecast, 2019-2026
9. North America Selected Reaction Monitoring Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Selected Reaction Monitoring Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Selected Reaction Monitoring Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Research Institutes
9.4.3. Diagnostic Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Selected Reaction Monitoring Market Size and Volume Forecast by Type
9.7.1. Human Discovery Assay
9.7.2. Human Cancer MRM Assay
9.7.3. Custom MRM Assays
9.7.4. Human Cardiovascular MRM Assay
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Selected Reaction Monitoring Demand Share Forecast, 2019-2026
10. Latin America Selected Reaction Monitoring Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Selected Reaction Monitoring Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Selected Reaction Monitoring Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Research Institutes
10.4.3. Diagnostic Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Selected Reaction Monitoring Market Size and Volume Forecast by Type
10.7.1. Human Discovery Assay
10.7.2. Human Cancer MRM Assay
10.7.3. Custom MRM Assays
10.7.4. Human Cardiovascular MRM Assay
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Selected Reaction Monitoring Demand Share Forecast, 2019-2026
11. Europe Selected Reaction Monitoring Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Selected Reaction Monitoring Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Selected Reaction Monitoring Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Research Institutes
11.4.3. Diagnostic Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Selected Reaction Monitoring Market Size and Volume Forecast by Type
11.7.1. Human Discovery Assay
11.7.2. Human Cancer MRM Assay
11.7.3. Custom MRM Assays
11.7.4. Human Cardiovascular MRM Assay
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Selected Reaction Monitoring Demand Share, 2019-2026
12. Asia Pacific Selected Reaction Monitoring Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Selected Reaction Monitoring Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Selected Reaction Monitoring Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Research Institutes
12.4.3. Diagnostic Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Selected Reaction Monitoring Market Size and Volume Forecast by Type
12.7.1. Human Discovery Assay
12.7.2. Human Cancer MRM Assay
12.7.3. Custom MRM Assays
12.7.4. Human Cardiovascular MRM Assay
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Selected Reaction Monitoring Demand Share, 2019-2026
13. Middle East & Africa Selected Reaction Monitoring Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Selected Reaction Monitoring Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Selected Reaction Monitoring Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Research Institutes
13.4.3. Diagnostic Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Selected Reaction Monitoring Market Size and Volume Forecast by Type
13.7.1. Human Discovery Assay
13.7.2. Human Cancer MRM Assay
13.7.3. Custom MRM Assays
13.7.4. Human Cardiovascular MRM Assay
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Selected Reaction Monitoring Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Selected Reaction Monitoring Market: Market Share Analysis
14.2. Selected Reaction Monitoring Distributors and Customers
14.3. Selected Reaction Monitoring Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. MRM Proteomics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sigma-Aldrich
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Alphalyse
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Proteomics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
